Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Outlook Therapeutics Inc (NASDAQ: OTLK) closed at $1.90 in the last session, up 1.60% from day before closing price of $1.87. In other words, the price has increased by $1.60 from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
We take a closer look at OTLK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.72.
On March 27, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $50.
Chardan Capital Markets Upgraded its Neutral to Buy on February 15, 2024, while the target price for the stock was maintained at $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.
Stock Price History:
Over the past 52 weeks, OTLK has reached a high of $9.25, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is 24.13%, while the 200-Day Moving Average is calculated to be -40.28%.
Shares Statistics:
A total of 32.91M shares are outstanding, with a floating share count of 21.22M. Insiders hold about 50.49% of the company’s shares, while institutions hold 16.68% stake in the company.
